<DOC>
	<DOCNO>NCT01486901</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial test bioequivalence two formulation Insulatard® healthy subject .</brief_summary>
	<brief_title>Bioequivalence Two Insulatard® Formulations Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Considered generally healthy upon completion medical history physical examination judge Investigator Body Mass Index ( BMI ) 18.0 27.0 kg/m^2 , inclusive Nonsmoker , define nicotine consumption least one year Fasting plasma glucose equal 100 mg/dL ( 5.6 mmol/L ) Previous participation trial clinical trial within last 3 month Body weight 87.5 kg Pregnant , breastfeed intention become pregnant use adequate contraceptive measure ( intrauterine device ( IUD ) place least 3 month , sterilisation , oral contraceptive pill , take without difficulty least 3 month , approve hormonal implant ) History alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>